These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28284978)

  • 1. Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks.
    Bernstein JA; Relan A; Harper JR; Riedl M
    Ann Allergy Asthma Immunol; 2017 Apr; 118(4):452-455. PubMed ID: 28284978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks.
    Li HH; Moldovan D; Bernstein JA; Reshef A; Porebski G; Stobiecki M; Baker J; Levy R; Relan A; Riedl M
    J Allergy Clin Immunol Pract; 2015; 3(3):417-23. PubMed ID: 25680925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.
    Baker JW; Bernstein JA; Harper JR; Relan A; Riedl MA
    Allergy Asthma Proc; 2018 Sep; 39(5):359-364. PubMed ID: 29954477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.
    Riedl MA; Levy RJ; Suez D; Lockey RF; Baker JW; Relan A; Zuraw BL
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):295-9. PubMed ID: 23535096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial.
    Riedl MA; Bernstein JA; Li H; Reshef A; Lumry W; Moldovan D; Farkas H; Levy R; Baker J; Hardiman Y; Totoritis MC; Relan A; Cicardi M;
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):163-169.e1. PubMed ID: 24468257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
    Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Relan A; Visscher S; Haase G; Kaufman L; Hack CE
    J Allergy Clin Immunol; 2010 Oct; 126(4):821-827.e14. PubMed ID: 20920772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.
    Li HH; Reshef A; Baker JW; Harper JR; Relan A
    Allergy Asthma Proc; 2017 Nov; 38(6):456-461. PubMed ID: 28874235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study.
    Reshef A; Moldovan D; Obtulowicz K; Leibovich I; Mihaly E; Visscher S; Relan A
    Allergy; 2013 Jan; 68(1):118-24. PubMed ID: 23121116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.
    Riedl MA; Li HH; Cicardi M; Harper JR; Relan A
    Allergy Asthma Proc; 2017 Nov; 38(6):462-466. PubMed ID: 28903805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk.
    Reshef A; Zanichelli A; Longhurst H; Relan A; Hack CE
    Allergy; 2015 May; 70(5):506-13. PubMed ID: 25640891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.
    Riedl MA; Hurewitz DS; Levy R; Busse PJ; Fitts D; Kalfus I
    Ann Allergy Asthma Immunol; 2012 Jan; 108(1):49-53. PubMed ID: 22192966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
    Reshef A; Grivcheva-Panovska V; Kessel A; Kivity S; Klimaszewska-Rembiasz M; Moldovan D; Farkas H; Gutova V; Fritz S; Relan A; Giannetti B; Magerl M
    Pediatr Allergy Immunol; 2019 Aug; 30(5):562-568. PubMed ID: 30993784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency.
    Farkas H; Csuka D; Veszeli N; Zotter Z; Szabó E; Varga L
    Allergy Asthma Proc; 2014; 35(3):255-9. PubMed ID: 24801469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
    Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.
    Baker JW; Reshef A; Moldovan D; Harper JR; Relan A; Riedl MA
    J Allergy Clin Immunol Pract; 2017; 5(4):1091-1097. PubMed ID: 28202404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant C1-inhibitor: effects on coagulation and fibrinolysis in patients with hereditary angioedema.
    Relan A; Bakhtiari K; van Amersfoort ES; Meijers JC; Hack CE
    BioDrugs; 2012 Feb; 26(1):43-52. PubMed ID: 22171564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant C1 inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedema.
    Manson AL; Dempster J; Grigoriadou S; Buckland MS; Longhurst HJ
    Eur J Dermatol; 2014; 24(1):28-34. PubMed ID: 24556385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
    Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
    Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema.
    Henry Li H; Riedl M; Kashkin J
    Clin Rev Allergy Immunol; 2019 Apr; 56(2):207-218. PubMed ID: 29909591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency.
    Andrási N; Veszeli N; Holdonner Á; Temesszentandrási G; Kőhalmi KV; Varga L; Farkas H
    Int Immunopharmacol; 2020 Mar; 80():106216. PubMed ID: 31982824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.